PHARMANUTRA SPA (PHN.MI) Stock Earnings & Estimates
Europe - BIT:PHN - IT0005274094 - Common Stock
39.5 EUR
-0.7 (-1.74%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 82.724M 21.45% | 100.202M 21.13% | 115.498M 15.27% | 132.87M 15.04% | 149.99M 12.88% | 163.82M 9.22% | N/A | N/A | N/A | N/A | |
| EBITDA YoY % growth | 24.392M 20.10% | 26.512M 8.69% | 31.575M 19.10% | 34.98M 10.78% | 39.525M 12.99% | 44.541M 12.69% | 40.898M -8.18% | 43.441M 6.22% | 45.781M 5.39% | 47.409M 3.56% | |
| EBIT YoY % growth | 23.074M 21.95% | 23.388M 1.36% | 27.646M 18.21% | 30.048M 8.69% | 35.148M 16.97% | 38.936M 10.78% | 36.116M -7.24% | 38.354M 6.20% | 40.491M 5.57% | 42.017M 3.77% | |
| Operating Margin | 27.89% | 23.34% | 23.94% | 22.61% | 23.43% | 23.77% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 1.56 15.55% | 1.33 -14.74% | N/A 43.02% | 2.16 13.36% | 2.52 16.86% | 2.84 12.63% | N/A | N/A | N/A | N/A |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.44 69.23% | 0.43 | 0.01 | 1.31% |
| Q4 2023 Q2Q % growth | 0.32 39.13% | 0.40 | -0.08 | -20.79% |
| Q3 2023 Q2Q % growth | 0.26 -45.83% | 0.27 | -0.01 | -4.66% |
| Q2 2023 Q2Q % growth | 0.19 -61.22% | 0.45 | -0.26 | -58.20% |
| Q1 2023 Q2Q % growth | 0.56 55.56% | 0.44 | 0.12 | 26.01% |
| Q4 2022 Q2Q % growth | 0.23 -23.33% | 0.24 | -0.01 | -5.12% |
| Q3 2022 Q2Q % growth | 0.48 23.08% | 0.42 | 0.06 | 14.52% |
| Q2 2022 Q2Q % growth | 0.49 4.26% | 2.50 | -2.01 | -80.40% |
| Q1 2022 Q2Q % growth | 0.36 | 0.31 | 0.05 | 14.98% |
| Q4 2021 Q2Q % growth | 0.30 | 0.23 | 0.07 | 32.01% |
| Q3 2021 Q2Q % growth | 0.39 | 0.26 | 0.13 | 48.51% |
| Q2 2021 Q2Q % growth | 0.47 | 0.38 | 0.09 | 22.46% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 61.877M 10.35% | % | ||
| Q1 2025 Q2Q % growth | 26.383M 11.20% | % | ||
| Q4 2024 Q2Q % growth | 59.425M 99.35% | % | ||
| Q3 2024 Q2Q % growth | 27.397M 25.66% | 25.553M | 1.844M | 7.22% |
| Q2 2024 Q2Q % growth | 56.073M 115.47% | % | ||
| Q1 2024 Q2Q % growth | 23.726M 0.50% | % | ||
| Q4 2023 Q2Q % growth | 29.81M -30.70% | 26.765M | 3.045M | 11.38% |
| Q3 2023 Q2Q % growth | 21.802M 6.05% | 21.917M | -115K | -0.52% |
| Q2 2023 Q2Q % growth | 26.024M -34.47% | 26.058M | -34K | -0.13% |
| Q1 2023 Q2Q % growth | 23.608M 25.31% | 23.23M | 378K | 1.63% |
| Q4 2022 Q2Q % growth | 43.013M 20.01% | 21.816M | 21.197M | 97.16% |
| Q3 2022 Q2Q % growth | 20.559M 20.70% | 19.897M | 662K | 3.33% |
| Q2 2022 Q2Q % growth | 39.711M 23.05% | 20.503M | 19.208M | 93.68% |
| Q1 2022 Q2Q % growth | 18.84M 32.32% | 17.928M | 912K | 5.09% |
| Q4 2021 Q2Q % growth | 35.841M 31.11% | 18.887M | 16.954M | 89.77% |
| Q3 2021 Q2Q % growth | 17.033M | 17.322M | -289K | -1.67% |
| Q2 2021 Q2Q % growth | 32.273M 10.86% | 18.332M | 13.941M | 76.05% |
| Q4 2020 Q2Q % growth | 27.337M -4.50% | % | ||
| Q2 2020 Q2Q % growth | 29.112M 16.54% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | -2.66% |
| Revenue | N/A | N/A | 0.58% | 0.24% |